MARCHETTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 513
EU - Europa 214
AS - Asia 121
AF - Africa 1
SA - Sud America 1
Totale 850
Nazione #
US - Stati Uniti d'America 505
SE - Svezia 58
SG - Singapore 40
IT - Italia 36
DE - Germania 29
GB - Regno Unito 29
HK - Hong Kong 29
CN - Cina 26
FI - Finlandia 19
ID - Indonesia 14
RU - Federazione Russa 9
CA - Canada 8
SI - Slovenia 7
BG - Bulgaria 6
AT - Austria 5
MY - Malesia 5
LT - Lituania 3
NL - Olanda 3
PL - Polonia 3
IN - India 2
VN - Vietnam 2
AD - Andorra 1
BE - Belgio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
FR - Francia 1
HU - Ungheria 1
IR - Iran 1
PH - Filippine 1
RO - Romania 1
TR - Turchia 1
ZM - Zambia 1
Totale 850
Città #
Santa Clara 108
Chandler 90
Ashburn 56
Fairfield 50
Nyköping 44
Singapore 37
Hong Kong 29
Helsinki 19
Jakarta 14
San Diego 14
Woodbridge 14
Seattle 13
London 11
Southend 11
Houston 10
Princeton 9
Bremen 8
Cambridge 8
Ann Arbor 7
Fremont 7
New York 7
Wilmington 7
Genoa 6
Munich 6
Ottawa 5
Shanghai 5
Sofia 5
Beijing 4
Bologna 4
Milan 4
Moscow 3
Alexandria 2
Berlin 2
Catania 2
Chicago 2
Dong Ket 2
Edinburgh 2
Frankfurt am Main 2
Hounslow 2
Leawood 2
Modena 2
Rome 2
San Mateo 2
Santa Maria Di Licodia 2
Stockholm 2
Toronto 2
Vienna 2
Warsaw 2
Amsterdam 1
Andorra la Vella 1
Andover 1
Angeles City 1
Bangalore 1
Bari 1
Brno 1
Brussels 1
Bucharest 1
Budapest 1
Cervia 1
Copenhagen 1
Dallas 1
Falkenstein 1
Hanover 1
Istanbul 1
Jacksonville 1
Kilburn 1
Lombard 1
Los Angeles 1
Lusaka 1
Manchester 1
Nanjing 1
New Orleans 1
Phoenix 1
Saint-Etienne 1
San Giorgio a Cremano 1
Zanjan 1
Totale 677
Nome #
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 137
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 132
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 109
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 93
Measuring breathability and bacterial filtration efficiency of face masks in the pandemic context: A round robin study with proficiency testing among non-accredited laboratories 88
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 79
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 78
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 76
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 69
Totale 861
Categoria #
all - tutte 5.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.985


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 28 39 4 11 11 4 15 3
2021/2022124 1 5 7 0 6 5 13 4 17 8 24 34
2022/2023279 44 33 24 21 31 29 11 29 20 0 16 21
2023/2024124 7 8 10 15 29 10 14 9 0 7 3 12
2024/2025219 13 6 4 41 75 75 5 0 0 0 0 0
Totale 861